Eirini Schlosser, Dyania Health
1) What is Dyania?
Dyania Health is a venture-backed company founded in 2020 focused on the development of their Synapsis A.I. technology which uses natural language processing and data analytics to automate the process of manual chart review of EMR’s. Synapsis can be deployed in isolated EMR-based servers to pre-screen patients for clinical studies, as well as build synthetic retrospective EMR data sets for external control arms or market access studies. Synapsis A.I. features a temporally sensitive ability which can pinpoint combinations of dynamically changing clinical characteristics in EMR’s over time. The engineering team is led by senior ex-Amazon Alexa NLP scientists and combines with a clinical advisory and in-house physician team developing a rule-based clinical decision engine.
2) What are you excited about for the next 12 months?
Dyania is uniquely positioned to ride the wave of the rapidly evolving NLP innovations that have been rising the last 18 months, having a world-class tech team with steep NLP expertise. Our cutting edge-technology and our streamlined deployment process has already given Dyania a competitive advantage versus the conventional, shallow techniques and time-consuming processes used by the majority of our competitors and as a result we are receiving growing inbound requests from big pharma and leading healthcare systems. Moreover, recent updates in the regulatory landscape led to the creation of more use cases of Dyania’s technology for pharma companies, offering new business development opportunities for Dyania to tap on in the next 12 months.
3) What have you enjoyed about working with Tau?
Tau team’s AI-first focus and expertise makes them great partners and supporters in Dyania’s growth. The partners’ long expertise and network in healthcare and AI industry has already been used to Dyania’s benefit, helping us expand our own network of partners and prospect clients.
